Where does Indus Biotech Private Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Indus Biotech Private Limited ranks #22,772 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Indus Biotech Private Limited hold?

Indus Biotech Private Limited holds 12 US utility patents granted between 2015 and 2020, spanning 10 technology areas.

What is Indus Biotech Private Limited's Innovation Score?

Indus Biotech Private Limited has an Innovation Score of 28.1 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Indus Biotech Private Limited focus on?

Indus Biotech Private Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 12 patents, ranking #1,593 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Indus Biotech Private Limited's patent grant rate increasing or decreasing?

Indus Biotech Private Limited's recent grant velocity is -91% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Indus Biotech Private Limited's patents?

Indus Biotech Private Limited's patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Indus Biotech Private Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Indus Biotech Private Limited

USPTO PatentsView assignee record - 12 granted patents across 10 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Indus ranks #22,772 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 10 technology areas.

#22,772
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.1/100): 13.5
avg claims per patent: -91%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22772 · Foreign Corporation #22,772 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,772/49,997
PHOTO-FINISH Imperial Toy
CPC-FOCUS A61P · 10 areas
INNOV-THIN 28.1/100
CLAIMS-RICH 13.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -91% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Imperial Toy LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Indus’s 28.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (32%) Velocity 0.0 pts (0%) Breadth 11.2 pts (40%) Claim depth 8.1 pts (29%)

Qualcomm Incorporated · highest

85
Indus Biotech Private · this assignee

28
3D Lighting… · lowest

7

What this shows Indus's Innovation Score is 28.1/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Indus?

Each dot is one of Indus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Indus’s own 13.5 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Indus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Indus's grants concentrate

Indus Biotech Private Limited is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2019. By volume, Indus sits between Imperial Toy LLC and Innogy Innovation GmbH.

Imperial Toy

12
Inbicon A/S

12
Indigo

12
Inductoheat

12
Infineon Canada

12
Inflarx

12
Inmode

12
Innogy Innovation

12
Indus Biotech Pri… ◀

12

What this shows Indus holds 12 patents at rank #22,787, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Indus

By rank, the assignees closest to #22,787 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Indus's primary technology class.

Indus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Indus Biotech Private Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	16.7%
2016	2	16.7%
2017	4	33.3%
2018	2	16.7%
2019	1	8.3%
2020	1	8.3%

Which technologies does Indus Biotech Private Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C08B - POLYSACCHARIDES; Derivatives Thereof 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C07C - Acyclic OR Carbocyclic Compounds 2

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

C08L - Compositions OF Macromolecular Compounds 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Indus Biotech Private Limited's patent record in context - here's where to go next.

Indus Biotech Private Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #22,772 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Indus Biotech Private Limited against Imperial Toy LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.